ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional Accepts healthy volunteers

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

ClinicalTrials.gov ID: NCT06649110

Public ClinicalTrials.gov record NCT06649110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)

Study identification

NCT ID
NCT06649110
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
232 participants

Conditions and interventions

Interventions

  • LTP Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2024
Primary completion
Nov 28, 2028
Completion
Dec 30, 2028
Last update posted
Apr 28, 2026

2024 โ€“ 2028

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Arizona Pulmonary Specialists Ltd Scottsdale Arizona 85258 Recruiting
UC Irvine Medical Center Orange California 92868-3298 Recruiting
Stanford Medical Center Stanford California 94305 Recruiting
Univ Colorado Hospital Aurora Colorado 80045 Recruiting
Central Florida Pulmonary Group Orlando Florida 32803-5734 Recruiting
University of South Florida Tampa Florida 33606-3475 Recruiting
Emory University School of Medicine Atlanta Georgia 30322 Recruiting
U of Kansas Medical Center Kansas City Kansas 66160 Recruiting
Norton Infectious Diseases Specialists Louisville Kentucky 40202 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Recruiting
Lahey Hospital and Medical Center Burlington Massachusetts 01805 Recruiting
Sky Integrative Medical Center SKYCRNG PPDS Ridgeland Mississippi 39157-5179 Recruiting
Summit Health Eastside Clinic Bend Oregon 97701 Recruiting
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4756 Recruiting
Statcare Pulmonary Consultants Knoxville Tennessee 37919 Recruiting
PPD Development LP Austin Texas 78744 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
The University of Utah Salt Lake City Utah 84132-0001 Recruiting
Pul Ass Richmond Inc P A R Richmond Virginia 23230-1709 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06649110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 ยท Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06649110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record โ†’